From Protein Structure to Small-Molecules: Recent Advances and Applications to Fragment-Based Drug Discovery

Author(s): Leonardo G. Ferreira, Adriano D. Andricopulo*

Journal Name: Current Topics in Medicinal Chemistry

Volume 17 , Issue 20 , 2017

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Fragment-based drug discovery (FBDD) is a broadly used strategy in structure-guided ligand design, whereby low-molecular weight hits move from lead-like to drug-like compounds. Over the past 15 years, an increasingly important role of the integration of these strategies into industrial and academic research platforms has been successfully established, allowing outstanding contributions to drug discovery. One important factor for the current prominence of FBDD is the better coverage of the chemical space provided by fragment-like libraries. The development of the field relies on two features: (i) the growing number of structurally characterized drug targets and (ii) the enormous chemical diversity available for experimental and virtual screenings. Indeed, fragment-based campaigns have contributed to address major challenges in lead optimization, such as the appropriate physicochemical profile of clinical candidates. This perspective paper outlines the usefulness and applications of FBDD approaches in medicinal chemistry and drug design.

Keywords: SBDD, FBDD, X-ray crystallography, NMR, Screening, Lead optimization.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Page: [2260 - 2270]
Pages: 11
DOI: 10.2174/1568026617666170224113437
Price: $65

Article Metrics

PDF: 101
HTML: 17